Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn’s Disease

被引：0
|
作者：
Jonathan M. Rhodes
Sreedhar Subramanian
Paul K. Flanagan
Graham W. Horgan
Kate Martin
John Mansfield
Miles Parkes
Ailsa Hart
Helen Dallal
Tariq Iqbal
Jeffrey Butterworth
Kate Culshaw
Christopher Probert
机构：
[1] University of Liverpool,Henry Wellcome Laboratory, Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, Royal Liverpool University Hospital
[2] Wirral University Teaching Hospital,undefined
[3] Biomathematics and Statistics Scotland,undefined
[4] Newcastle upon Tyne Hospitals,undefined
[5] Cambridge University Hospitals,undefined
[6] St Mark’s Hospital,undefined
[7] James Cook University Hospital,undefined
[8] Queen Elizabeth Hospital Birmingham,undefined
[9] Shrewsbury and Telford Hospital,undefined
[10] Liverpool Cancer Trials Unit,undefined
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Crohn’s disease; Antibiotics; Ciprofloxacin; Doxycycline; Hydroxychloroquine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2700 / 2711
页数：11
相关论文
共 50 条
  • [1] Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease
    Rhodes, Jonathan M.
    Subramanian, Sreedhar
    Flanagan, Paul K.
    Horgan, Graham W.
    Martin, Kate
    Mansfield, John
    Parkes, Miles
    Hart, Ailsa
    Dallal, Helen
    Iqbal, Tariq
    Butterworth, Jeffrey
    Culshaw, Kate
    Probert, Christopher
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (08) : 2700 - 2711
  • [2] Randomised open-label controlled trial of ciprofloxacin/doxycycline/hydroxychloroquine combination compared with standard budesonide in active Crohn's disease (APRICOT)
    Rhodes, J. M.
    Subramanian, S.
    Flanagan, P.
    Horgan, G.
    Martin, K.
    Mansfield, J.
    Parkes, M.
    Hart, A.
    Dallal, H.
    Iqbal, T.
    Butterworth, J.
    Culshaw, K.
    Probert, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S487 - S487
  • [3] RANDOMISED CONTROLLED TRIAL OF ANTIBIOTIC/HYDROXYCHLOROQUINE COMBINATION VERSUS STANDARD BUDESONIDE IN ACTIVE CROHN'S DISEASE (APRICOT)
    Rhodes, Jonathan
    Subramanian, Sreedhar
    Flanagan, Paul
    Horgan, Graham
    Martin, Kate
    Mansfield, John
    Parkes, Miles
    Hart, Ailsa
    Dallal, Helen
    Iqbal, Tariq
    Butterworth, Jeff
    Culshaw, Kate
    Probert, Christopher
    GUT, 2021, 70 : A4 - A5
  • [4] Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial
    Steinhart, AH
    Feagan, BG
    Greenberg, GR
    Wong, CJ
    Vandervoort, M
    Mikolainis, S
    Croitoru, K
    Seidman, EG
    Leddin, DJ
    Drouin, E
    Bitton, A
    Cohen, A
    GASTROENTEROLOGY, 2001, 120 (05) : A126 - A127
  • [5] Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial
    Steinhart, AH
    Feagan, BG
    Wong, CJ
    Vandervoort, M
    Mikolainis, S
    Croitoru, K
    Seidman, E
    Leddin, DJ
    Bitton, A
    Drouin, E
    Cohen, A
    Greenberg, GR
    GASTROENTEROLOGY, 2002, 123 (01) : 33 - 40
  • [6] Budesonide versus prednisone in the treatment of active Crohn's disease
    Bar-Meir, S
    Chowers, Y
    Lavy, A
    Abramovitch, D
    Sternberg, A
    Leichtmann, G
    Reshef, R
    Odes, S
    Moshkovitz, M
    Bruck, R
    Eliakim, R
    Maoz, E
    Mittmann, U
    GASTROENTEROLOGY, 1998, 115 (04) : 835 - 840
  • [7] Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial
    Escher, JC
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (01) : 47 - 54
  • [8] Budesonide capsules versus prednisolone in children with active Crohn's disease: Results of a European multicenter trial
    Escher, JC
    Lindquist, B
    Hildebrand, H
    Cezard, JP
    Derkx, B
    Ferry, G
    Grand, R
    Griffiths, A
    Goulet, O
    Keller, K
    Lentze, M
    Murch, S
    Murphy, S
    Miller, V
    Mougenot, JF
    Ribes-Koninck, C
    Sanderson, I
    Taminiau, J
    Taylor, C
    Thomas, A
    Turck, D
    Veereman-Wauters, G
    Walker-Smith, J
    Winter, H
    Lyckegaard, EMS
    Persson, T
    Buller, H
    GASTROENTEROLOGY, 2002, 122 (04) : A12 - A12
  • [9] Budesonide or prednisolone in active Crohn's disease
    Baert, F
    Rutgeerts, P
    ANNALS OF MEDICINE, 1995, 27 (06) : 631 - 631
  • [10] Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease
    Leiper, K.
    Martin, K.
    Ellis, A.
    Watson, A. J. M.
    Morris, A. I.
    Rhodes, J. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) : 1233 - 1239
12345